{
    "N/R/U": "N",
    "Applicant": "Novavax, Inc.",
    "BLA Number": "125817",
    "Proprietary Name": "NUVAXOVID",
    "Proper Name": "COVID-19 Vaccine, Adjuvanted",
    "BLA Type": "351(a)",
    "Strength": "5UG",
    "Dosage Form": "Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "May 16, 2025",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2349",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}